GeneDx Holdings Corp. (WGS), Monday reported preliminary results, representing a year-over-year increase of 59 percent and 54 percent for the fourth quarter and full year 2024, respectively.
Revenue for the quarter is expected to be atleast $92 million, whereas the same is predicted to be atleast $299 million for the full year 2024.
Analysts, on average, predict revenue of $80.22 million for the fourth quarter, and $288.2 million for the full year 2024.
Currently, GeneDx's stock is moving down 4.13 percent, to $85.69 on the Nasdaq.
For comments and feedback contact: editorial@rttnews.com
Business News
June 19, 2026 16:46 ET Major central banks continued to dominate the economic news flow this week too, led by the Federal Reserve, as they announced their latest policy decisions. The Federal Reserve policy session was in focus as it was the first to be led by the new chief Kevin Warsh. In Europe, central banks of the U.K. and Switzerland announced their rate decisions. In Asia, the Bank of Japan drew attention for its policy moves, while data out of China threw some light on the state of the economy.